Serum ceruloplasmin levels in preeclampsia: a meta-analysis

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3123055 47 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Serum ceruloplasmin levels in preeclampsia: a meta-analysis
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Purpose: To evaluate the differences in serum ceruloplasmin levels between patients with preeclampsia and healthy controls. Materials and methods: We searched the Medline (1966–2017), Scopus (2004–2017), Clinicaltrials.gov (2008–2017), Cochrane Central Register of Controlled Trials CENTRAL (1999–2017), and Google Scholar (2004–2017) databases. Meta-analysis was performed with the RevMan 5.3 software. Results: Fifteen studies were finally included in the present review, with a total number of 1927 women. Maternal serum ceruloplasmin concentration was significantly higher in preeclamptic than in the healthy pregnant women (mean differences (MD): 12.57 mg/dl, 95% CI: [8.81, 16.33]). Ceruloplasmin levels were significantly higher both in mild (MD: 13.8 mg/dl, 95% CI: [2.64, 23.53]) and severe (MD: 21.84 mg/dl, 95% CI: [0.97, 42.71]) preeclampsia, when compared to the control group. The severity of the disease did not significantly affect the levels of the protein (MD: −9.34 mg/dl, 95% CI: [−20.93, 2.26]). Conclusions: Serum ceruloplasmin may be a useful screening and follow-up tool for the evaluation of pregnant women with an indicative history of developing preeclampsia. Future studies are needed to evaluate the levels of this specific protein throughout the pregnancy course and provide data on its sensitivity and specificity by introducing cut-off values. © 2017 Informa UK Limited, trading as Taylor & Francis Group.
Έτος δημοσίευσης:
2018
Συγγραφείς:
Bellos, I.
Papantoniou, N.
Pergialiotis, V.
Περιοδικό:
Journal of Maternal-Fetal and Neonatal Medicine
Εκδότης:
Taylor and Francis Ltd.
Τόμος:
31
Αριθμός / τεύχος:
17
Σελίδες:
2342-2348
Λέξεις-κλειδιά:
biological marker; ceruloplasmin; ceruloplasmin, clinical evaluation; clinical practice; comparative study; disease course; disease marker; disease severity; follow up; human; maternal serum; maternal serum screening test; pathophysiology; preeclampsia; pregnant woman; priority journal; protein blood level; Review; sensitivity analysis; adult; blood; case control study; female; meta analysis; metabolism; preeclampsia; pregnancy; severity of illness index, Adult; Case-Control Studies; Ceruloplasmin; Female; Humans; Pre-Eclampsia; Pregnancy; Severity of Illness Index
Επίσημο URL (Εκδότης):
DOI:
10.1080/14767058.2017.1340449
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.